A coronavirus vaccine designed entirely by artificial intelligence has passed its first test in humans. The results, announced June 5, 2026, and published in the Journal of Infection, showed the vaccine is safe, well-tolerated, and capable of generating immune responses against multiple coronavirus strains, including SARS-CoV-2 and related bat viruses with pandemic potential.
It is a genuine milestone. It is also an early Phase 1 trial in 39 people. Clinical approval is years away.